This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations of Angus John MacDonald
Introduction
Angus John MacDonald is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of immunology, particularly in the detection of human IL-21. His work has implications for diagnostics and therapeutic regimens in various medical conditions.
Latest Patents
Angus John MacDonald holds a patent for "Methods of detecting human IL-21." This patent includes antibodies or antigen-binding fragments that specifically bind to human IL-21. These antibodies are instrumental in immunoassays for measuring IL-21 levels and can be utilized in various imaging methods for diagnostic, prognostic, and predictive purposes. The patent emphasizes the importance of IL-21 signaling in pathogenesis, thereby optimizing therapeutic regimens for affected patients. He has 1 patent to his name.
Career Highlights
Angus John MacDonald is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His role at the company allows him to contribute to innovative research and development in the field of immunology. His expertise and dedication have positioned him as a valuable asset in the scientific community.
Collaborations
Some of his notable coworkers include Stuart W Bright and Julian Davies. Their collaborative efforts enhance the research environment and foster innovation within their projects.
Conclusion
Angus John MacDonald exemplifies the spirit of innovation in the field of immunology through his patent and work at Eli Lilly and Company. His contributions are vital for advancing diagnostic and therapeutic strategies in medicine.